Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035715 | SCV000059366 | likely benign | not specified | 2008-10-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000829024 | SCV000970734 | likely benign | not provided | 2018-04-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001084901 | SCV001009308 | likely benign | Hypertrophic cardiomyopathy | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381293 | SCV002693087 | likely benign | Cardiovascular phenotype | 2022-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV003531915 | SCV004356949 | likely benign | Cardiomyopathy | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Cohesion Phenomics | RCV001084901 | SCV003803693 | benign | Hypertrophic cardiomyopathy | 2022-09-27 | no assertion criteria provided | clinical testing |